-
Dr. Jessica Duncan Shares Perspective on Updated Dietary Guidelines in 2026 | The David Webb Show
Dr. Jessica Duncan, MD, DABOM, Medical Director at Ivím Health, recently returned to The David Webb Show on SiriusXM Patriot Channel 125. In this interview, Dr. Duncan shares perspective on the newly released 2025-2030 Dietary Guidelines for […]
-
Dr. Jessica Duncan on The David Webb Show
Dr. Jessica Duncan, MD, DABOM, Medical Director at Ivím Health, recently joined The David Webb Show on SiriusXM Patriot Channel 125. In this interview, Dr. Duncan shares perspective on topics including nutrition education in medical training and […]
-
Ivim Health Unveils GLP-1 ID: Precision Dosing Meets Individualized Care
A new standard in GLP-1 therapy that individualizes dosing and patient care for better results, with potentially fewer side effects, and long-term success. COLUMBUS, OHIO — August 12, 2025 — With demand for GLP-1 medications at an […]
-
New IVIM Study Shows 21.8% Average Weight Loss Over 68 Weeks – Exceeding Outcomes Reported in Landmark GLP-1 Trials
A new publication reveals breakthrough results in GLP-1 obesity management using Ivim Health’s individualized virtual integrative medicine (IVIM) protocol. (Not a head-to-head trial. Results may vary) COLUMBUS, OH – July 28, 2025 — A new landmark, peer-reviewed […]
-
Ivím at Work, Offered by Ivím Health and Xevant, Named Gold Stevie® Award Winner in 2025 American Business Awards®
Ivím at Work, a joint solution from Ivím Health and Xevant, has been named the winner of the Gold Stevie® Award in the Consumer Products category in the 23rd Annual American Business Awards®. The American Business Awards are […]
-
Ivim Health Supports the Outsourcing Facilities Association’s Appeal of Court Ruling That Further Restricts Access to Compounded GLP-1 Medications
Recent Federal Court Ruling Denying Request for an Injunction Will Endanger Patients by Limiting Access to Critical Weight Loss & Diabetes Drugs (COLUMBUS, Ohio, March 10, 2025) –Ivim Health (Ivim), a leading telehealth platform comprised of obesity […]
-
Ivím Health Raises Alarm as FDA Deadline Threatens Obesity Treatment Access
March 4, 2024 COLUMBUS, OHIO – In recognition of World Obesity Day, Ivim Health is proud to advocate on behalf of patients on their health journeys by providing personalized and effective care, guided by medical professionals who […]
-
Ivim Health Files Amicus Brief Fighting for Patient Access to GLP-1 Medications as Critical March Deadline Looms
FOR IMMEDIATE RELEASE February 4, 2025 Advocating for Patients as Regulatory Changes Threaten Life-Changing Treatments Columbus, OH – February 4, 2025 – In an Amicus Brief submitted today in Outsourcing Facilities Association v. FDA in the U.S. […]
-
Ivim Health Asks Robert F. Kennedy, Jr., Nominee for Secretary of HHS, to Focus on Patient Access and Affordability
COLUMBUS, Ohio, December 30, 2024 — Dear Mr. Kennedy, My name is Dr. Taylor Kantor, and I am joined in writing this letter by my colleague, Dr. Jessica Duncan. We are reaching out to bring attention to […]
-
Ivim Health Launches Comprehensive Corporate Wellness Programs to Revolutionize Workplace Health
COLUMBUS, Ohio, Nov. 4, 2024 — Ivim Health, a leader in personalized healthcare solutions with a 4.9-star TrustPilot rating and over 600,000 registered patients, is expanding its direct to consumer offerings to launch its innovative Ivim at Work corporate wellness programs. […]








